114 related articles for article (PubMed ID: 15001974)
21. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
Zhang D; Ma J; Brismar K; Efendic S; Gu HF
J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
[TBL] [Abstract][Full Text] [Related]
22. Resequencing of the vascular endothelial growth factor promoter reveals haplotype structure and functional diversity.
Radovich M; Hancock BA; Kassem N; Mi D; Skaar TC; Schneider BP
Angiogenesis; 2010 Sep; 13(3):211-8. PubMed ID: 20552269
[TBL] [Abstract][Full Text] [Related]
23. Sex steroid levels and cortical bone size in young men are associated with a uridine diphosphate glucuronosyltransferase 2B7 polymorphism (H268Y).
Swanson C; Lorentzon M; Vandenput L; Labrie F; Rane A; Jakobsson J; Chouinard S; Bélanger A; Ohlsson C
J Clin Endocrinol Metab; 2007 Sep; 92(9):3697-704. PubMed ID: 17579197
[TBL] [Abstract][Full Text] [Related]
24. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J
J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820
[TBL] [Abstract][Full Text] [Related]
25. Identification and functional significance of polymorphisms in the mu-opioid receptor gene (Oprm) promoter of C57BL/6 and DBA/2 mice.
Doyle GA; Sheng XR; Schwebel CL; Ferraro TN; Berrettini WH; Buono RJ
Neurosci Res; 2006 Jul; 55(3):244-54. PubMed ID: 16644048
[TBL] [Abstract][Full Text] [Related]
26. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level.
Kathiresan S; Larson MG; Vasan RS; Guo CY; Gona P; Keaney JF; Wilson PW; Newton-Cheh C; Musone SL; Camargo AL; Drake JA; Levy D; O'Donnell CJ; Hirschhorn JN; Benjamin EJ
Circulation; 2006 Mar; 113(11):1415-23. PubMed ID: 16534007
[TBL] [Abstract][Full Text] [Related]
27. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.
Kang MY; Lee BB; Ji YI; Jung EH; Chun HK; Song SY; Park SE; Park J; Kim DH
Cancer; 2008 Apr; 112(8):1699-707. PubMed ID: 18327804
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphisms of MRP2 and UGT2B7 and gastrointestinal symptoms in renal transplant recipients taking mycophenolic acid.
Yang JW; Lee PH; Hutchinson IV; Pravica V; Shah T; Min DI
Ther Drug Monit; 2009 Oct; 31(5):542-8. PubMed ID: 19730281
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel 12-nucleotide insertion polymorphism in the promoter region of ADRA2B: full linkage with the 9-nucleotide deletion in the coding region and influence on transcriptional activity.
Crassous PA; Blaise R; Marquette A; Snapir A; Scheinin M; Paris H; Schaak S
Biochem Pharmacol; 2010 Feb; 79(3):407-12. PubMed ID: 19728989
[TBL] [Abstract][Full Text] [Related]
31. [Correlation of serum IL-18 level and IL-18 gene promoter polymorphisms to the risk of cervical cancer].
Qi T; Wang Q; Zheng L; Yang HL; Bao J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):754-7. PubMed ID: 18504197
[TBL] [Abstract][Full Text] [Related]
32. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
33. Clinical response to morphine in cancer patients and genetic variation in candidate genes.
Ross JR; Rutter D; Welsh K; Joel SP; Goller K; Wells AU; Du Bois R; Riley J
Pharmacogenomics J; 2005; 5(5):324-36. PubMed ID: 16103897
[TBL] [Abstract][Full Text] [Related]
34. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.
Frisdal E; Klerkx AH; Le Goff W; Tanck MW; Lagarde JP; Jukema JW; Kastelein JJ; Chapman MJ; Guerin M
Hum Mol Genet; 2005 Sep; 14(18):2607-18. PubMed ID: 16049032
[TBL] [Abstract][Full Text] [Related]
35. Association between UGT2B7 gene polymorphisms and fentanyl sensitivity in patients undergoing painful orthognathic surgery.
Muraoka W; Nishizawa D; Fukuda K; Kasai S; Hasegawa J; Wajima K; Nakagawa T; Ikeda K
Mol Pain; 2016; 12():1744806916683182. PubMed ID: 28256933
[TBL] [Abstract][Full Text] [Related]
36. Lack of genetic association between OCT1, ABCB1, and UGT2B7 variants and morphine pharmacokinetics.
Nielsen LM; Sverrisdóttir E; Stage TB; Feddersen S; Brøsen K; Christrup LL; Drewes AM; Olesen AE
Eur J Pharm Sci; 2017 Mar; 99():337-342. PubMed ID: 28063968
[TBL] [Abstract][Full Text] [Related]
37. UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients.
Tian JN; Ho IK; Tsou HH; Fang CP; Hsiao CF; Chen CH; Tan HK; Lin L; Wu CS; Su LW; Huang CL; Yang YH; Liu ML; Chen YT; Liu SC; Hsu YT; Kuo HW; Liu CT; Yang YT; Chen ACh; Shih YH; Liu YL
Pharmacogenomics; 2012 Jun; 13(8):879-88. PubMed ID: 22676193
[TBL] [Abstract][Full Text] [Related]
38. Expression-based discovery of variation in the human glutathione S-transferase M3 promoter and functional analysis in a glioma cell line using allele-specific chromatin immunoprecipitation.
Liu X; Campbell MR; Pittman GS; Faulkner EC; Watson MA; Bell DA
Cancer Res; 2005 Jan; 65(1):99-104. PubMed ID: 15665284
[TBL] [Abstract][Full Text] [Related]
39. Oral Morphine Pharmacokinetic in Obesity: The Role of P-Glycoprotein, MRP2, MRP3, UGT2B7, and CYP3A4 Jejunal Contents and Obesity-Associated Biomarkers.
Lloret-Linares C; Miyauchi E; Luo H; Labat L; Bouillot JL; Poitou C; Oppert JM; Laplanche JL; Mouly S; Scherrmann JM; Uchida Y; Tachikawa M; Terasaki T; Bergmann JF; Declèves X
Mol Pharm; 2016 Mar; 13(3):766-73. PubMed ID: 26751618
[TBL] [Abstract][Full Text] [Related]
40. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.
Zhang X; Miao X; Tan W; Ning B; Liu Z; Hong Y; Song W; Guo Y; Zhang X; Shen Y; Qiang B; Kadlubar FF; Lin D
Gastroenterology; 2005 Aug; 129(2):565-76. PubMed ID: 16083713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
